| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural molecule activity | KRT1 KRT2 KRT27 LORICRIN KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 8.95e-14 | 891 | 16 | 12 | GO:0005198 |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 5.46e-13 | 43 | 16 | 6 | GO:0030280 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 4.46e-08 | 130 | 16 | 5 | GO:0005200 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 2.94e-24 | 75 | 16 | 11 | GO:0045109 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 7.52e-23 | 99 | 16 | 11 | GO:0045104 |
| GeneOntologyBiologicalProcess | intermediate filament-based process | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 8.44e-23 | 100 | 16 | 11 | GO:0045103 |
| GeneOntologyBiologicalProcess | skin development | 2.41e-14 | 373 | 16 | 10 | GO:0043588 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | KRT1 KRT2 KRT27 LORICRIN KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 4.59e-14 | 870 | 16 | 12 | GO:0030855 |
| GeneOntologyBiologicalProcess | epidermis development | 2.01e-13 | 461 | 16 | 10 | GO:0008544 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 5.18e-13 | 189 | 16 | 8 | GO:0030216 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 7.15e-12 | 957 | 16 | 11 | GO:0097435 |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 1.37e-11 | 284 | 16 | 8 | GO:0009913 | |
| GeneOntologyBiologicalProcess | epithelium development | KRT1 KRT2 KRT27 LORICRIN KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 2.27e-11 | 1469 | 16 | 12 | GO:0060429 |
| GeneOntologyBiologicalProcess | keratinization | 3.66e-11 | 87 | 16 | 6 | GO:0031424 | |
| GeneOntologyBiologicalProcess | peptide cross-linking | 4.19e-09 | 27 | 16 | 4 | GO:0018149 | |
| GeneOntologyBiologicalProcess | protein heterotetramerization | 6.73e-05 | 16 | 16 | 2 | GO:0051290 | |
| GeneOntologyBiologicalProcess | keratinocyte development | 7.62e-05 | 17 | 16 | 2 | GO:0003334 | |
| GeneOntologyBiologicalProcess | keratinocyte migration | 1.17e-04 | 21 | 16 | 2 | GO:0051546 | |
| GeneOntologyBiologicalProcess | molting cycle | 1.97e-04 | 150 | 16 | 3 | GO:0042303 | |
| GeneOntologyBiologicalProcess | hair cycle | 1.97e-04 | 150 | 16 | 3 | GO:0042633 | |
| GeneOntologyBiologicalProcess | protein heterooligomerization | 2.59e-04 | 31 | 16 | 2 | GO:0051291 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 2.65e-04 | 166 | 16 | 3 | GO:0098773 | |
| GeneOntologyBiologicalProcess | positive regulation of epidermis development | 2.94e-04 | 33 | 16 | 2 | GO:0045684 | |
| GeneOntologyBiologicalProcess | establishment of skin barrier | 4.55e-04 | 41 | 16 | 2 | GO:0061436 | |
| GeneOntologyBiologicalProcess | regulation of epidermis development | 1.36e-03 | 71 | 16 | 2 | GO:0045682 | |
| GeneOntologyBiologicalProcess | stem cell differentiation | 1.57e-03 | 306 | 16 | 3 | GO:0048863 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 3.40e-03 | 113 | 16 | 2 | GO:0051262 | |
| GeneOntologyCellularComponent | intermediate filament | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 8.08e-19 | 227 | 16 | 11 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 4.19e-18 | 263 | 16 | 11 | GO:0045111 |
| GeneOntologyCellularComponent | keratin filament | 7.59e-18 | 97 | 16 | 9 | GO:0045095 | |
| GeneOntologyCellularComponent | cornified envelope | 3.49e-14 | 69 | 16 | 7 | GO:0001533 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 3.14e-12 | 899 | 16 | 11 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 5.90e-11 | 1179 | 16 | 11 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 6.35e-11 | 1187 | 16 | 11 | GO:0099081 |
| HumanPheno | Congenital bullous ichthyosiform erythroderma | 1.18e-11 | 4 | 11 | 4 | HP:0007475 | |
| HumanPheno | Abnormal epidermal morphology | 1.81e-10 | 94 | 11 | 7 | HP:0011124 | |
| HumanPheno | Hypergranulosis | 4.19e-10 | 22 | 11 | 5 | HP:0025114 | |
| HumanPheno | Epidermal acanthosis | 4.74e-10 | 54 | 11 | 6 | HP:0025092 | |
| HumanPheno | Knuckle pad | 8.21e-10 | 8 | 11 | 4 | HP:0032541 | |
| HumanPheno | Palmoplantar hyperkeratosis | 1.72e-09 | 129 | 11 | 7 | HP:0000972 | |
| HumanPheno | Palmar hyperkeratosis | 1.92e-09 | 131 | 11 | 7 | HP:0010765 | |
| HumanPheno | Plantar hyperkeratosis | 2.03e-09 | 132 | 11 | 7 | HP:0007556 | |
| HumanPheno | Hyperkeratosis | 2.50e-09 | 233 | 11 | 8 | HP:0000962 | |
| HumanPheno | Abnormality of keratinization | 3.61e-09 | 244 | 11 | 8 | HP:0001035 | |
| HumanPheno | Congenital ichthyosiform erythroderma | 3.74e-09 | 33 | 11 | 5 | HP:0007431 | |
| HumanPheno | Abnormality of the plantar skin of foot | 1.25e-08 | 171 | 11 | 7 | HP:0100872 | |
| HumanPheno | Palmoplantar keratoderma | 4.65e-08 | 114 | 11 | 6 | HP:0000982 | |
| HumanPheno | Abnormal blistering of the skin | 4.90e-08 | 115 | 11 | 6 | HP:0008066 | |
| HumanPheno | Epidermal thickening | 1.18e-07 | 379 | 11 | 8 | HP:0011368 | |
| HumanPheno | Thickened skin | 3.24e-07 | 431 | 11 | 8 | HP:0001072 | |
| HumanPheno | Palmoplantar blistering | 1.22e-06 | 11 | 11 | 3 | HP:0007446 | |
| HumanPheno | Diffuse palmoplantar hyperkeratosis | 1.22e-06 | 11 | 11 | 3 | HP:0007447 | |
| HumanPheno | Epidermal hyperkeratosis | 1.22e-06 | 11 | 11 | 3 | HP:0007543 | |
| HumanPheno | Erythema | 4.58e-06 | 133 | 11 | 5 | HP:0010783 | |
| HumanPheno | Abnormal skin morphology of the palm | 5.43e-06 | 413 | 11 | 7 | HP:0040211 | |
| HumanPheno | Ichthyosis | 6.79e-06 | 144 | 11 | 5 | HP:0008064 | |
| HumanPheno | Orthokeratosis | 8.37e-06 | 20 | 11 | 3 | HP:0040162 | |
| HumanPheno | Blistering by anatomical location | 1.90e-05 | 26 | 11 | 3 | HP:0033800 | |
| HumanPheno | Skin erosion | 2.38e-05 | 28 | 11 | 3 | HP:0200041 | |
| HumanPheno | Abnormal nail morphology | 2.41e-05 | 516 | 11 | 7 | HP:0001597 | |
| HumanPheno | Hyperparakeratosis | 2.54e-05 | 4 | 11 | 2 | HP:0040009 | |
| HumanPheno | Abnormal palm morphology | 2.57e-05 | 521 | 11 | 7 | HP:0100871 | |
| HumanPheno | Onychogryposis | 2.66e-05 | 29 | 11 | 3 | HP:0001805 | |
| HumanPheno | Regional abnormality of skin | 3.31e-05 | 541 | 11 | 7 | HP:0011356 | |
| HumanPheno | Parakeratosis | 3.95e-05 | 33 | 11 | 3 | HP:0001036 | |
| HumanPheno | Papule | 4.18e-05 | 209 | 11 | 5 | HP:0200034 | |
| HumanPheno | Impaired temperature sensation | 4.32e-05 | 34 | 11 | 3 | HP:0010829 | |
| HumanPheno | Abnormality of temperature sensation | 4.32e-05 | 34 | 11 | 3 | HP:0100772 | |
| HumanPheno | Impaired tactile sensation | 5.59e-05 | 37 | 11 | 3 | HP:0010830 | |
| HumanPheno | Abnormal fingernail morphology | 6.64e-05 | 230 | 11 | 5 | HP:0001231 | |
| HumanPheno | Flexion contracture of finger | 8.15e-05 | 240 | 11 | 5 | HP:0005651 | |
| HumanPheno | Camptodactyly (hands) | 8.15e-05 | 240 | 11 | 5 | HP:0010563 | |
| HumanPheno | Camptodactyly of toe | 8.15e-05 | 240 | 11 | 5 | HP:0001836 | |
| HumanPheno | Joint contractures involving the joints of the feet | 8.15e-05 | 240 | 11 | 5 | HP:0100492 | |
| HumanPheno | Camptodactyly of finger | 8.15e-05 | 240 | 11 | 5 | HP:0100490 | |
| HumanPheno | Flexion contracture of toe | 8.15e-05 | 240 | 11 | 5 | HP:0005830 | |
| HumanPheno | Interphalangeal joint contracture of finger | 8.15e-05 | 240 | 11 | 5 | HP:0001220 | |
| HumanPheno | Toe joint contracture | 8.31e-05 | 241 | 11 | 5 | HP:0034675 | |
| HumanPheno | Localized skin lesion | 8.97e-05 | 897 | 11 | 8 | HP:0011355 | |
| HumanPheno | Abnormality of skin adnexa physiology | 9.72e-05 | 249 | 11 | 5 | HP:0025276 | |
| HumanPheno | Scaling skin | 1.08e-04 | 46 | 11 | 3 | HP:0040189 | |
| HumanPheno | Flexion contracture of finger | 1.13e-04 | 257 | 11 | 5 | HP:0012785 | |
| HumanPheno | Skin plaque | 1.15e-04 | 47 | 11 | 3 | HP:0200035 | |
| HumanPheno | Finger joint contracture | 1.17e-04 | 259 | 11 | 5 | HP:0034681 | |
| HumanPheno | Abnormal sweat gland morphology | 1.20e-04 | 260 | 11 | 5 | HP:0000971 | |
| HumanPheno | Abnormal phalangeal joint morphology of the hand | 1.24e-04 | 262 | 11 | 5 | HP:0006261 | |
| HumanPheno | Nail dysplasia | 1.29e-04 | 264 | 11 | 5 | HP:0002164 | |
| HumanPheno | Joint contractures | 2.08e-04 | 292 | 11 | 5 | HP:0001372 | |
| HumanPheno | Clubbing | 2.14e-04 | 152 | 11 | 4 | HP:0001217 | |
| HumanPheno | Joint contracture of the hand | 2.21e-04 | 296 | 11 | 5 | HP:0009473 | |
| HumanPheno | Conjunctival nodule | 2.31e-04 | 11 | 11 | 2 | HP:0009903 | |
| HumanPheno | Conjunctival hamartoma | 2.31e-04 | 11 | 11 | 2 | HP:0100780 | |
| HumanPheno | Amniotic constriction ring | 2.31e-04 | 11 | 11 | 2 | HP:0009775 | |
| HumanPheno | Nail dystrophy | 2.36e-04 | 156 | 11 | 4 | HP:0008404 | |
| HumanPheno | Hyperhidrosis | 3.07e-04 | 167 | 11 | 4 | HP:0000975 | |
| HumanPheno | Hyperkeratotic papule | 3.26e-04 | 13 | 11 | 2 | HP:0045059 | |
| HumanPheno | Abnormal placental membrane morphology | 3.80e-04 | 14 | 11 | 2 | HP:0011409 | |
| HumanPheno | Foot joint contracture | 3.91e-04 | 334 | 11 | 5 | HP:0008366 | |
| HumanPheno | Camptodactyly | 4.61e-04 | 346 | 11 | 5 | HP:0012385 | |
| HumanPheno | Upper-limb joint contracture | 5.69e-04 | 362 | 11 | 5 | HP:0100360 | |
| HumanPheno | Flexion contracture of digit | 5.69e-04 | 362 | 11 | 5 | HP:0030044 | |
| HumanPheno | Abnormal fingertip morphology | 6.48e-04 | 203 | 11 | 4 | HP:0001211 | |
| HumanPheno | Lower-limb joint contracture | 9.36e-04 | 403 | 11 | 5 | HP:0005750 | |
| HumanPheno | Hypohidrosis or hyperhidrosis | 1.13e-03 | 235 | 11 | 4 | HP:0007550 | |
| HumanPheno | Congenital nonbullous ichthyosiform erythroderma | 1.14e-03 | 24 | 11 | 2 | HP:0007479 | |
| HumanPheno | Abnormal exteroceptive sensation | 1.62e-03 | 259 | 11 | 4 | HP:0033747 | |
| HumanPheno | Cutaneous photosensitivity | 1.75e-03 | 118 | 11 | 3 | HP:0000992 | |
| HumanPheno | Hamartoma of the orbital region | 1.78e-03 | 30 | 11 | 2 | HP:0030670 | |
| HumanPheno | Hamartoma of the eye | 1.78e-03 | 30 | 11 | 2 | HP:0010568 | |
| HumanPheno | Limb joint contracture | 1.87e-03 | 469 | 11 | 5 | HP:0003121 | |
| HumanPheno | Fragile skin | 2.71e-03 | 37 | 11 | 2 | HP:0001030 | |
| HumanPheno | Anhidrosis | 2.86e-03 | 38 | 11 | 2 | HP:0000970 | |
| HumanPheno | Lower limb pain | 3.32e-03 | 41 | 11 | 2 | HP:0012514 | |
| HumanPheno | Pruritus | 3.41e-03 | 149 | 11 | 3 | HP:0000989 | |
| HumanPheno | Hoarse voice | 4.09e-03 | 159 | 11 | 3 | HP:0001609 | |
| HumanPheno | Neoplasm of the eye | 4.72e-03 | 49 | 11 | 2 | HP:0100012 | |
| HumanPheno | Nevus | 4.94e-03 | 170 | 11 | 3 | HP:0003764 | |
| HumanPheno | Poor appetite | 5.10e-03 | 51 | 11 | 2 | HP:0004396 | |
| HumanPheno | Vascular skin abnormality | 5.33e-03 | 593 | 11 | 5 | HP:0011276 | |
| HumanPheno | Abnormal conjunctiva morphology | 5.45e-03 | 176 | 11 | 3 | HP:0000502 | |
| MousePheno | abnormal epidermis stratum corneum morphology | 3.11e-13 | 132 | 15 | 8 | MP:0001240 | |
| MousePheno | abnormal epidermal layer morphology | 1.03e-10 | 271 | 15 | 8 | MP:0001216 | |
| MousePheno | abnormal skin physiology | 1.67e-10 | 288 | 15 | 8 | MP:0005501 | |
| MousePheno | hyperkeratosis | 2.87e-10 | 90 | 15 | 6 | MP:0001242 | |
| MousePheno | abnormal skin appearance | 8.46e-09 | 473 | 15 | 8 | MP:0009931 | |
| MousePheno | blistering | 9.01e-09 | 24 | 15 | 4 | MP:0001208 | |
| MousePheno | abnormal foot pad morphology | 1.27e-08 | 26 | 15 | 4 | MP:0000574 | |
| MousePheno | hyperpigmentation | 1.73e-08 | 28 | 15 | 4 | MP:0001188 | |
| MousePheno | acanthosis | 1.03e-07 | 43 | 15 | 4 | MP:0001874 | |
| MousePheno | epidermis stratum spinosum hyperplasia | 1.25e-07 | 45 | 15 | 4 | MP:0009611 | |
| MousePheno | abnormal skin morphology | 2.66e-07 | 1455 | 15 | 10 | MP:0002060 | |
| MousePheno | impaired skin barrier function | 5.25e-07 | 64 | 15 | 4 | MP:0002796 | |
| MousePheno | abnormal epidermis stratum spinosum morphology | 5.59e-07 | 65 | 15 | 4 | MP:0001236 | |
| MousePheno | abnormal skin pigmentation | 1.81e-06 | 87 | 15 | 4 | MP:0002095 | |
| MousePheno | abnormal epidermis stratum basale morphology | 7.60e-06 | 37 | 15 | 3 | MP:0001231 | |
| MousePheno | abnormal keratinocyte morphology | 2.40e-05 | 54 | 15 | 3 | MP:0002655 | |
| MousePheno | scaly skin | 2.54e-05 | 55 | 15 | 3 | MP:0001192 | |
| MousePheno | abnormal skin coloration | 3.39e-05 | 182 | 15 | 4 | MP:0011239 | |
| MousePheno | hypergranulosis | 3.85e-05 | 9 | 15 | 2 | MP:0009600 | |
| MousePheno | abnormal epidermis stratum granulosum morphology | 5.24e-05 | 70 | 15 | 3 | MP:0001239 | |
| MousePheno | thick epidermis stratum granulosum | 7.05e-05 | 12 | 15 | 2 | MP:0009599 | |
| MousePheno | increased tail pigmentation | 7.05e-05 | 12 | 15 | 2 | MP:0011276 | |
| MousePheno | thick epidermis | 7.82e-05 | 80 | 15 | 3 | MP:0001219 | |
| MousePheno | abnormal keratinocyte physiology | 8.11e-05 | 81 | 15 | 3 | MP:0003453 | |
| MousePheno | neonatal lethality | 1.10e-04 | 799 | 15 | 6 | MP:0002058 | |
| MousePheno | translucent skin | 1.12e-04 | 15 | 15 | 2 | MP:0001201 | |
| MousePheno | abnormal epidermis suprabasal layer morphology | 1.12e-04 | 15 | 15 | 2 | MP:0001233 | |
| MousePheno | increased foot pigmentation | 1.28e-04 | 16 | 15 | 2 | MP:0030051 | |
| MousePheno | increased foot pad pigmentation | 1.28e-04 | 16 | 15 | 2 | MP:0000575 | |
| MousePheno | abnormal corneocyte morphology | 1.63e-04 | 18 | 15 | 2 | MP:0030605 | |
| MousePheno | skin inflammation | 1.75e-04 | 105 | 15 | 3 | MP:0004947 | |
| MousePheno | flaky skin | 2.23e-04 | 21 | 15 | 2 | MP:0001195 | |
| MousePheno | waved hair | 2.23e-04 | 21 | 15 | 2 | MP:0000410 | |
| MousePheno | increased skin papilloma incidence | 2.45e-04 | 22 | 15 | 2 | MP:0002051 | |
| MousePheno | abnormal tongue morphology | 2.48e-04 | 118 | 15 | 3 | MP:0000762 | |
| MousePheno | enlarged sebaceous gland | 2.68e-04 | 23 | 15 | 2 | MP:0000652 | |
| MousePheno | rough coat | 2.93e-04 | 24 | 15 | 2 | MP:0010179 | |
| MousePheno | decreased skin tensile strength | 3.44e-04 | 26 | 15 | 2 | MP:0003089 | |
| MousePheno | pigmentation phenotype | 3.60e-04 | 624 | 15 | 5 | MP:0001186 | |
| MousePheno | increased keratinocyte proliferation | 3.71e-04 | 27 | 15 | 2 | MP:0009583 | |
| MousePheno | abnormal tongue epithelium morphology | 3.71e-04 | 27 | 15 | 2 | MP:0000764 | |
| MousePheno | abnormal foot pigmentation | 4.00e-04 | 28 | 15 | 2 | MP:0009379 | |
| MousePheno | abnormal skin tensile strength | 5.23e-04 | 32 | 15 | 2 | MP:0005275 | |
| MousePheno | increased papilloma incidence | 5.57e-04 | 33 | 15 | 2 | MP:0002014 | |
| MousePheno | abnormal autopod morphology | 6.38e-04 | 390 | 15 | 4 | MP:0000572 | |
| MousePheno | abnormal head morphology | 6.94e-04 | 1120 | 15 | 6 | MP:0000432 | |
| MousePheno | perinatal lethality | 7.28e-04 | 1130 | 15 | 6 | MP:0002081 | |
| MousePheno | abnormal tail pigmentation | 7.78e-04 | 39 | 15 | 2 | MP:0005174 | |
| MousePheno | abnormal keratinocyte proliferation | 8.60e-04 | 41 | 15 | 2 | MP:0009582 | |
| MousePheno | increased skin tumor incidence | 1.04e-03 | 45 | 15 | 2 | MP:0010300 | |
| MousePheno | abnormal pilosebaceous unit morphology | 1.24e-03 | 205 | 15 | 3 | MP:0030572 | |
| MousePheno | thick skin | 1.38e-03 | 52 | 15 | 2 | MP:0001200 | |
| MousePheno | abnormal skin condition | 1.66e-03 | 227 | 15 | 3 | MP:0001191 | |
| MousePheno | abnormal hair growth | 1.79e-03 | 233 | 15 | 3 | MP:0002073 | |
| MousePheno | abnormal hair texture | 2.02e-03 | 63 | 15 | 2 | MP:0002074 | |
| MousePheno | craniofacial phenotype | 2.03e-03 | 1372 | 15 | 6 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 2.03e-03 | 1372 | 15 | 6 | MP:0000428 | |
| MousePheno | abnormal esophagus morphology | 2.22e-03 | 66 | 15 | 2 | MP:0000467 | |
| MousePheno | epidermal hyperplasia | 2.28e-03 | 67 | 15 | 2 | MP:0001222 | |
| MousePheno | abnormal sebaceous gland morphology | 2.93e-03 | 76 | 15 | 2 | MP:0000647 | |
| MousePheno | increased integument system tumor incidence | 2.93e-03 | 76 | 15 | 2 | MP:0010293 | |
| MousePheno | abnormal holocrine gland morphology | 2.93e-03 | 76 | 15 | 2 | MP:0013543 | |
| MousePheno | abnormal limb morphology | 3.43e-03 | 1028 | 15 | 5 | MP:0002109 | |
| MousePheno | neonatal lethality, incomplete penetrance | 3.61e-03 | 298 | 15 | 3 | MP:0011088 | |
| MousePheno | spina bifida | 3.81e-03 | 87 | 15 | 2 | MP:0003054 | |
| MousePheno | abnormal tumor incidence | 3.85e-03 | 635 | 15 | 4 | MP:0002019 | |
| MousePheno | abnormal tumor susceptibility | 4.19e-03 | 650 | 15 | 4 | MP:0002166 | |
| MousePheno | abnormal mouth morphology | 4.67e-03 | 670 | 15 | 4 | MP:0000452 | |
| MousePheno | neoplasm | 6.88e-03 | 747 | 15 | 4 | MP:0002006 | |
| MousePheno | abnormal outer ear morphology | 7.02e-03 | 119 | 15 | 2 | MP:0002177 | |
| MousePheno | increased classified tumor incidence | 7.16e-03 | 381 | 15 | 3 | MP:0010273 | |
| MousePheno | abnormal classified tumor incidence | 7.32e-03 | 384 | 15 | 3 | MP:0020188 | |
| MousePheno | abnormal coat appearance | 7.79e-03 | 774 | 15 | 4 | MP:0001510 | |
| MousePheno | increased organ/body region tumor incidence | 7.91e-03 | 395 | 15 | 3 | MP:0010274 | |
| MousePheno | increased cell proliferation | 7.97e-03 | 396 | 15 | 3 | MP:0000351 | |
| MousePheno | limbs/digits/tail phenotype | 8.16e-03 | 1258 | 15 | 5 | MP:0005371 | |
| Domain | Filament | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 4.57e-24 | 71 | 16 | 11 | SM01391 |
| Domain | IF | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 5.40e-24 | 72 | 16 | 11 | PS00226 |
| Domain | Filament | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 6.35e-24 | 73 | 16 | 11 | PF00038 |
| Domain | IF | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 1.02e-23 | 76 | 16 | 11 | IPR001664 |
| Domain | Keratin_I | 1.39e-23 | 44 | 16 | 10 | IPR002957 | |
| Domain | Intermediate_filament_CS | 7.10e-22 | 63 | 16 | 10 | IPR018039 | |
| Domain | Keratin_2_head | 3.78e-09 | 24 | 16 | 4 | PF16208 | |
| Domain | Keratin_2_head | 3.78e-09 | 24 | 16 | 4 | IPR032444 | |
| Domain | Keratin_II | 5.31e-09 | 26 | 16 | 4 | IPR003054 | |
| Domain | Prefoldin | 3.57e-07 | 72 | 16 | 4 | IPR009053 | |
| Domain | GrpE_coiled_coil | 4.52e-05 | 12 | 16 | 2 | IPR013805 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | KRT1 KRT2 KRT27 LORICRIN KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 3.61e-22 | 129 | 16 | 12 | M27649 |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 1.09e-21 | 87 | 16 | 11 | MM15351 |
| Pathway | REACTOME_KERATINIZATION | KRT1 KRT2 KRT27 LORICRIN KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 2.25e-19 | 217 | 16 | 12 | M27640 |
| Pathway | REACTOME_KERATINIZATION | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 7.13e-19 | 153 | 16 | 11 | MM15343 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 3.90e-13 | 502 | 16 | 11 | MM14537 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRT1 KRT2 KRT27 LORICRIN KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 SUZ12 KRT24 KRT16 | 4.87e-11 | 1432 | 16 | 13 | M509 |
| Pathway | REACTOME_DIFFERENTIATION_OF_KERATINOCYTES_IN_INTERFOLLICULAR_EPIDERMIS_IN_MAMMALIAN_SKIN | 6.06e-10 | 40 | 16 | 5 | M48231 | |
| Pubmed | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 | 1.19e-27 | 63 | 16 | 11 | 16831889 | |
| Pubmed | 3.97e-19 | 57 | 16 | 8 | 31862882 | ||
| Pubmed | 4.44e-18 | 266 | 16 | 10 | 19380743 | ||
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 1.04e-17 | 84 | 16 | 8 | 29563501 | |
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 2.03e-17 | 91 | 16 | 8 | 34445801 | |
| Pubmed | 1.64e-16 | 54 | 16 | 7 | 35474131 | ||
| Pubmed | 3.58e-16 | 60 | 16 | 7 | 31220272 | ||
| Pubmed | E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. | 5.24e-16 | 135 | 16 | 8 | 29859926 | |
| Pubmed | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 HNRNPA1L2 KRT14 KRT76 KRT24 KRT16 | 2.68e-15 | 1153 | 16 | 12 | 29845934 | |
| Pubmed | 2.63e-14 | 45 | 16 | 6 | 30619335 | ||
| Pubmed | 2.99e-14 | 4 | 16 | 4 | 32179842 | ||
| Pubmed | 3.02e-14 | 46 | 16 | 6 | 36147463 | ||
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 5.25e-14 | 238 | 16 | 8 | 35864588 | |
| Pubmed | 7.77e-14 | 438 | 16 | 9 | 21630459 | ||
| Pubmed | 1.19e-13 | 19 | 16 | 5 | 35173535 | ||
| Pubmed | 1.49e-13 | 5 | 16 | 4 | 2458356 | ||
| Pubmed | 1.49e-13 | 5 | 16 | 4 | 9665399 | ||
| Pubmed | 1.98e-13 | 62 | 16 | 6 | 26644517 | ||
| Pubmed | 2.05e-13 | 488 | 16 | 9 | 31324722 | ||
| Pubmed | HDM2-binding partners: interaction with translation elongation factor EF1alpha. | 2.09e-13 | 21 | 16 | 5 | 17373842 | |
| Pubmed | 2.51e-13 | 289 | 16 | 8 | 37132043 | ||
| Pubmed | 4.36e-13 | 24 | 16 | 5 | 30719818 | ||
| Pubmed | Transcription Factor MafB Coordinates Epidermal Keratinocyte Differentiation. | 4.36e-13 | 24 | 16 | 5 | 27208706 | |
| Pubmed | 4.48e-13 | 6 | 16 | 4 | 7525178 | ||
| Pubmed | Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. | 4.48e-13 | 6 | 16 | 4 | 14638864 | |
| Pubmed | 5.45e-13 | 25 | 16 | 5 | 23132931 | ||
| Pubmed | 6.45e-13 | 75 | 16 | 6 | 31527668 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 6.84e-13 | 558 | 16 | 9 | 27591049 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 7.53e-13 | 564 | 16 | 9 | 21565611 | |
| Pubmed | Mouse homologue of skin-specific retroviral-like aspartic protease involved in wrinkle formation. | 1.04e-12 | 7 | 16 | 4 | 16837463 | |
| Pubmed | Regulation of epidermal differentiation by a Distal-less homeodomain gene. | 1.04e-12 | 7 | 16 | 4 | 8991098 | |
| Pubmed | Calmodulin 4 is dispensable for epidermal barrier formation and wound healing in mice. | 2.09e-12 | 8 | 16 | 4 | 25316000 | |
| Pubmed | 2.09e-12 | 8 | 16 | 4 | 7543090 | ||
| Pubmed | 2.09e-12 | 8 | 16 | 4 | 19515043 | ||
| Pubmed | Aurora kinase-A deficiency during skin development impairs cell division and stratification. | 3.76e-12 | 9 | 16 | 4 | 22832491 | |
| Pubmed | A functional reference map of the RNF8 interactome in cancer. | 3.76e-12 | 218 | 16 | 7 | 35831895 | |
| Pubmed | Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. | 6.26e-12 | 10 | 16 | 4 | 14517554 | |
| Pubmed | Spatiotemporal expression pattern of keratins in skin of AP-2alpha-deficient mice. | 6.26e-12 | 10 | 16 | 4 | 10571739 | |
| Pubmed | Essential role for Sonic hedgehog during hair follicle morphogenesis. | 6.26e-12 | 10 | 16 | 4 | 9882493 | |
| Pubmed | Transcriptional regulation of Oct4 by a long non-coding RNA antisense to Oct4-pseudogene 5. | 6.72e-12 | 40 | 16 | 5 | 21151833 | |
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 8.02e-12 | 113 | 16 | 6 | 34474245 | |
| Pubmed | 9.83e-12 | 11 | 16 | 4 | 11171335 | ||
| Pubmed | p63 is a p53 homologue required for limb and epidermal morphogenesis. | 9.83e-12 | 11 | 16 | 4 | 10227293 | |
| Pubmed | Fate and plasticity of the epidermis in response to congenital activation of BRAF. | 2.13e-11 | 13 | 16 | 4 | 25202828 | |
| Pubmed | 2.13e-11 | 13 | 16 | 4 | 8999895 | ||
| Pubmed | 2.98e-11 | 14 | 16 | 4 | 27551807 | ||
| Pubmed | Multiple roles of Notch signaling in the regulation of epidermal development. | 4.06e-11 | 15 | 16 | 4 | 18410734 | |
| Pubmed | 4.06e-11 | 15 | 16 | 4 | 10087197 | ||
| Pubmed | 5.09e-11 | 59 | 16 | 5 | 26371508 | ||
| Pubmed | 5.42e-11 | 16 | 16 | 4 | 17631878 | ||
| Pubmed | Dissecting the Roles of Polycomb Repressive Complex 2 Subunits in the Control of Skin Development. | 5.42e-11 | 16 | 16 | 4 | 26994968 | |
| Pubmed | A crucial role of WW45 in developing epithelial tissues in the mouse. | 5.42e-11 | 16 | 16 | 4 | 18369314 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 6.53e-11 | 580 | 16 | 8 | 35676659 | |
| Pubmed | 7.17e-11 | 162 | 16 | 6 | 15174051 | ||
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 26581228 | ||
| Pubmed | 8.38e-11 | 65 | 16 | 5 | 29795372 | ||
| Pubmed | 9.10e-11 | 18 | 16 | 4 | 20335364 | ||
| Pubmed | Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. | 9.10e-11 | 18 | 16 | 4 | 19303854 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 9.12e-11 | 605 | 16 | 8 | 28977666 | |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 9.26e-11 | 169 | 16 | 6 | 23084401 | |
| Pubmed | 9.62e-11 | 346 | 16 | 7 | 25324306 | ||
| Pubmed | Mice deficient in involucrin, envoplakin, and periplakin have a defective epidermal barrier. | 1.15e-10 | 19 | 16 | 4 | 18166659 | |
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | 1.26e-10 | 630 | 16 | 8 | 36949045 | |
| Pubmed | 1.78e-10 | 21 | 16 | 4 | 22935613 | ||
| Pubmed | EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway. | 1.78e-10 | 21 | 16 | 4 | 33029523 | |
| Pubmed | 1.94e-10 | 191 | 16 | 6 | 33762435 | ||
| Pubmed | High proliferation and delamination during skin epidermal stratification. | 2.17e-10 | 22 | 16 | 4 | 34050161 | |
| Pubmed | 2.17e-10 | 22 | 16 | 4 | 19749746 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 2.25e-10 | 1070 | 16 | 9 | 23533145 | |
| Pubmed | 2.34e-10 | 197 | 16 | 6 | 23686814 | ||
| Pubmed | 3.16e-10 | 24 | 16 | 4 | 27507811 | ||
| Pubmed | 3.19e-10 | 4 | 16 | 3 | 7679677 | ||
| Pubmed | A mouse model of harlequin ichthyosis delineates a key role for Abca12 in lipid homeostasis. | 3.19e-10 | 4 | 16 | 3 | 18802465 | |
| Pubmed | 3.19e-10 | 4 | 16 | 3 | 7518402 | ||
| Pubmed | Expression of cytokeratins 10, 13, 14 and 19 in oral lichen planus. | 3.19e-10 | 4 | 16 | 3 | 19776502 | |
| Pubmed | 3.53e-10 | 417 | 16 | 7 | 19199708 | ||
| Pubmed | 3.76e-10 | 25 | 16 | 4 | 23271346 | ||
| Pubmed | 4.44e-10 | 26 | 16 | 4 | 15454262 | ||
| Pubmed | mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation. | 5.21e-10 | 27 | 16 | 4 | 27807348 | |
| Pubmed | Beclin 1 regulates recycling endosome and is required for skin development in mice. | 5.21e-10 | 27 | 16 | 4 | 30701202 | |
| Pubmed | 6.07e-10 | 28 | 16 | 4 | 38131461 | ||
| Pubmed | Sox21 Regulates Anapc10 Expression and Determines the Fate of Ectodermal Organ. | 6.07e-10 | 28 | 16 | 4 | 32674056 | |
| Pubmed | 7.98e-10 | 5 | 16 | 3 | 15922673 | ||
| Pubmed | 7.98e-10 | 5 | 16 | 3 | 9873228 | ||
| Pubmed | 8.12e-10 | 30 | 16 | 4 | 34905516 | ||
| Pubmed | 8.52e-10 | 803 | 16 | 8 | 36517590 | ||
| Pubmed | 9.33e-10 | 31 | 16 | 4 | 20930145 | ||
| Pubmed | ZFP750 affects the cutaneous barrier through regulating lipid metabolism. | 9.33e-10 | 31 | 16 | 4 | 37115925 | |
| Pubmed | 9.33e-10 | 31 | 16 | 4 | 22274697 | ||
| Pubmed | IKK1 control of epidermal differentiation is modulated by notch signaling. | 1.60e-09 | 6 | 16 | 3 | 21435444 | |
| Pubmed | Overexpression of Sonic Hedgehog suppresses embryonic hair follicle morphogenesis. | 1.60e-09 | 6 | 16 | 3 | 14597196 | |
| Pubmed | VAMP2 controls murine epidermal differentiation and carcinogenesis by regulation of nucleophagy. | 1.60e-09 | 6 | 16 | 3 | 38810653 | |
| Pubmed | 1.60e-09 | 6 | 16 | 3 | 12736219 | ||
| Pubmed | Development, structure, and keratin expression in C57BL/6J mouse eccrine glands. | 1.60e-09 | 6 | 16 | 3 | 22135020 | |
| Pubmed | 1.60e-09 | 6 | 16 | 3 | 19300453 | ||
| Pubmed | 2.10e-09 | 284 | 16 | 6 | 29459677 | ||
| Pubmed | 2.19e-09 | 286 | 16 | 6 | 32041737 | ||
| Pubmed | Jarid2 regulates mouse epidermal stem cell activation and differentiation. | 2.79e-09 | 7 | 16 | 3 | 21811233 | |
| Pubmed | Phosphorylation of Pkp1 by RIPK4 regulates epidermal differentiation and skin tumorigenesis. | 2.79e-09 | 7 | 16 | 3 | 28507225 | |
| Pubmed | 2.79e-09 | 7 | 16 | 3 | 10191051 | ||
| Interaction | KRT7 interactions | 1.72e-18 | 80 | 16 | 9 | int:KRT7 | |
| Interaction | KRT1 interactions | KRT1 KRT2 KRT27 LORICRIN KRT9 KRT10 KRT77 KRT13 KRT14 KRT24 KRT16 | 2.05e-18 | 238 | 16 | 11 | int:KRT1 |
| Interaction | KRT75 interactions | 2.03e-17 | 181 | 16 | 10 | int:KRT75 | |
| Interaction | KRT5 interactions | 3.91e-17 | 193 | 16 | 10 | int:KRT5 | |
| Interaction | RNF208 interactions | 3.15e-16 | 75 | 16 | 8 | int:RNF208 | |
| Interaction | KRT17 interactions | 5.86e-16 | 252 | 16 | 10 | int:KRT17 | |
| Interaction | PRPH interactions | 1.01e-14 | 204 | 16 | 9 | int:PRPH | |
| Interaction | KRT2 interactions | 3.79e-14 | 236 | 16 | 9 | int:KRT2 | |
| Interaction | HEXIM1 interactions | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 HNRNPA1L2 KRT14 KRT76 KRT24 KRT16 | 1.07e-13 | 913 | 16 | 12 | int:HEXIM1 |
| Interaction | DES interactions | 1.46e-13 | 158 | 16 | 8 | int:DES | |
| Interaction | KRT6A interactions | 1.61e-13 | 160 | 16 | 8 | int:KRT6A | |
| Interaction | KRT8 interactions | 1.62e-13 | 441 | 16 | 10 | int:KRT8 | |
| Interaction | ZUP1 interactions | 3.19e-13 | 174 | 16 | 8 | int:ZUP1 | |
| Interaction | KRT77 interactions | 4.92e-13 | 96 | 16 | 7 | int:KRT77 | |
| Interaction | KRT84 interactions | 1.18e-12 | 49 | 16 | 6 | int:KRT84 | |
| Interaction | SHC1 interactions | 1.81e-12 | 362 | 16 | 9 | int:SHC1 | |
| Interaction | CRK interactions | 2.20e-12 | 370 | 16 | 9 | int:CRK | |
| Interaction | MEPCE interactions | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 KRT13 HNRNPA1L2 KRT14 KRT76 KRT16 | 2.85e-12 | 859 | 16 | 11 | int:MEPCE |
| Interaction | CUL2 interactions | 2.98e-12 | 591 | 16 | 10 | int:CUL2 | |
| Interaction | NEDD8 interactions | 3.78e-12 | 393 | 16 | 9 | int:NEDD8 | |
| Interaction | CUL4B interactions | 2.34e-11 | 728 | 16 | 10 | int:CUL4B | |
| Interaction | AHI1 interactions | 3.15e-11 | 83 | 16 | 6 | int:AHI1 | |
| Interaction | KRT76 interactions | 3.39e-11 | 84 | 16 | 6 | int:KRT76 | |
| Interaction | KRT74 interactions | 6.78e-11 | 37 | 16 | 5 | int:KRT74 | |
| Interaction | WTAP interactions | 7.31e-11 | 194 | 16 | 7 | int:WTAP | |
| Interaction | EFNA1 interactions | 1.18e-10 | 103 | 16 | 6 | int:EFNA1 | |
| Interaction | CYLD interactions | 1.32e-10 | 868 | 16 | 10 | int:CYLD | |
| Interaction | DDX24 interactions | 1.55e-10 | 596 | 16 | 9 | int:DDX24 | |
| Interaction | EFNA3 interactions | 1.58e-10 | 108 | 16 | 6 | int:EFNA3 | |
| Interaction | RLIM interactions | 2.14e-10 | 392 | 16 | 8 | int:RLIM | |
| Interaction | PIK3R2 interactions | 2.41e-10 | 230 | 16 | 7 | int:PIK3R2 | |
| Interaction | NPHP4 interactions | 2.89e-10 | 236 | 16 | 7 | int:NPHP4 | |
| Interaction | DDX3X interactions | 3.39e-10 | 651 | 16 | 9 | int:DDX3X | |
| Interaction | KRT18 interactions | 3.63e-10 | 419 | 16 | 8 | int:KRT18 | |
| Interaction | DIRAS2 interactions | 4.01e-10 | 52 | 16 | 5 | int:DIRAS2 | |
| Interaction | KRT81 interactions | 4.43e-10 | 53 | 16 | 5 | int:KRT81 | |
| Interaction | KRT6B interactions | 5.34e-10 | 132 | 16 | 6 | int:KRT6B | |
| Interaction | RPS6KB2 interactions | 5.84e-10 | 261 | 16 | 7 | int:RPS6KB2 | |
| Interaction | MKS1 interactions | 7.31e-10 | 139 | 16 | 6 | int:MKS1 | |
| Interaction | KRT72 interactions | 7.71e-10 | 59 | 16 | 5 | int:KRT72 | |
| Interaction | KRT79 interactions | 7.71e-10 | 59 | 16 | 5 | int:KRT79 | |
| Interaction | KRT4 interactions | 9.95e-10 | 62 | 16 | 5 | int:KRT4 | |
| Interaction | KRT19 interactions | 1.00e-09 | 282 | 16 | 7 | int:KRT19 | |
| Interaction | KRT20 interactions | 1.08e-09 | 63 | 16 | 5 | int:KRT20 | |
| Interaction | CHD3 interactions | 1.28e-09 | 757 | 16 | 9 | int:CHD3 | |
| Interaction | EIF3F interactions | 1.40e-09 | 296 | 16 | 7 | int:EIF3F | |
| Interaction | LARP7 interactions | KRT1 KRT2 KRT27 KRT9 KRT10 KRT77 HNRNPA1L2 KRT14 KRT76 KRT16 | 1.50e-09 | 1113 | 16 | 10 | int:LARP7 |
| Interaction | UBASH3B interactions | 1.52e-09 | 157 | 16 | 6 | int:UBASH3B | |
| Interaction | CBL interactions | 1.88e-09 | 516 | 16 | 8 | int:CBL | |
| Interaction | VIM interactions | 2.18e-09 | 804 | 16 | 9 | int:VIM | |
| Interaction | MINDY4 interactions | 2.30e-09 | 73 | 16 | 5 | int:MINDY4 | |
| Interaction | C1orf216 interactions | 2.30e-09 | 73 | 16 | 5 | int:C1orf216 | |
| Interaction | KRT6C interactions | 2.82e-09 | 76 | 16 | 5 | int:KRT6C | |
| Interaction | CUL5 interactions | 3.94e-09 | 567 | 16 | 8 | int:CUL5 | |
| Interaction | DDX39B interactions | 4.11e-09 | 570 | 16 | 8 | int:DDX39B | |
| Interaction | KRT10 interactions | 4.37e-09 | 187 | 16 | 6 | int:KRT10 | |
| Interaction | CUL1 interactions | 4.62e-09 | 876 | 16 | 9 | int:CUL1 | |
| Interaction | KRT14 interactions | 5.12e-09 | 192 | 16 | 6 | int:KRT14 | |
| Interaction | CAND1 interactions | 5.52e-09 | 894 | 16 | 9 | int:CAND1 | |
| Interaction | KRT78 interactions | 5.62e-09 | 87 | 16 | 5 | int:KRT78 | |
| Interaction | KRT3 interactions | 5.95e-09 | 88 | 16 | 5 | int:KRT3 | |
| Interaction | KRT16 interactions | 5.97e-09 | 197 | 16 | 6 | int:KRT16 | |
| Interaction | IQCB1 interactions | 6.59e-09 | 370 | 16 | 7 | int:IQCB1 | |
| Interaction | TEDC2 interactions | 7.80e-09 | 206 | 16 | 6 | int:TEDC2 | |
| Interaction | FGD5 interactions | 8.03e-09 | 207 | 16 | 6 | int:FGD5 | |
| Interaction | CHD4 interactions | 8.40e-09 | 938 | 16 | 9 | int:CHD4 | |
| Interaction | PHGDH interactions | 8.67e-09 | 385 | 16 | 7 | int:PHGDH | |
| Interaction | INPPL1 interactions | 9.80e-09 | 214 | 16 | 6 | int:INPPL1 | |
| Interaction | MYCN interactions | KRT1 KRT2 LORICRIN KRT9 KRT10 KRT77 HNRNPA1L2 KRT14 SUZ12 SP7 | 1.14e-08 | 1373 | 16 | 10 | int:MYCN |
| Interaction | EPS15 interactions | 1.16e-08 | 220 | 16 | 6 | int:EPS15 | |
| Interaction | KRT25 interactions | 1.37e-08 | 35 | 16 | 4 | int:KRT25 | |
| Interaction | RC3H2 interactions | 1.41e-08 | 667 | 16 | 8 | int:RC3H2 | |
| Interaction | EVPL interactions | 1.53e-08 | 106 | 16 | 5 | int:EVPL | |
| Interaction | ARF5 interactions | 1.55e-08 | 231 | 16 | 6 | int:ARF5 | |
| Interaction | RNF8 interactions | 1.61e-08 | 421 | 16 | 7 | int:RNF8 | |
| Interaction | AP2M1 interactions | 1.86e-08 | 430 | 16 | 7 | int:AP2M1 | |
| Interaction | EFNA4 interactions | 1.89e-08 | 239 | 16 | 6 | int:EFNA4 | |
| Interaction | KRT35 interactions | 1.93e-08 | 111 | 16 | 5 | int:KRT35 | |
| Interaction | NPHP3 interactions | 2.91e-08 | 42 | 16 | 4 | int:NPHP3 | |
| Interaction | KRT71 interactions | 3.21e-08 | 43 | 16 | 4 | int:KRT71 | |
| Interaction | COPS5 interactions | 3.42e-08 | 1102 | 16 | 9 | int:COPS5 | |
| Interaction | MAGOH interactions | 3.43e-08 | 264 | 16 | 6 | int:MAGOH | |
| Interaction | DCUN1D1 interactions | 4.37e-08 | 275 | 16 | 6 | int:DCUN1D1 | |
| Interaction | EIF4A3 interactions | 5.16e-08 | 499 | 16 | 7 | int:EIF4A3 | |
| Interaction | METTL3 interactions | 5.62e-08 | 287 | 16 | 6 | int:METTL3 | |
| Interaction | HGS interactions | 7.11e-08 | 523 | 16 | 7 | int:HGS | |
| Interaction | ARL4D interactions | 7.63e-08 | 146 | 16 | 5 | int:ARL4D | |
| Interaction | METTL14 interactions | 1.11e-07 | 558 | 16 | 7 | int:METTL14 | |
| Interaction | KRT85 interactions | 1.35e-07 | 61 | 16 | 4 | int:KRT85 | |
| Interaction | FBP1 interactions | 1.76e-07 | 348 | 16 | 6 | int:FBP1 | |
| Interaction | HDAC6 interactions | 1.83e-07 | 929 | 16 | 8 | int:HDAC6 | |
| Interaction | THRB interactions | 2.55e-07 | 186 | 16 | 5 | int:THRB | |
| Interaction | KRT36 interactions | 2.95e-07 | 74 | 16 | 4 | int:KRT36 | |
| Interaction | KRT86 interactions | 3.11e-07 | 75 | 16 | 4 | int:KRT86 | |
| Interaction | ALB interactions | 3.49e-07 | 391 | 16 | 6 | int:ALB | |
| Interaction | KRT27 interactions | 3.84e-07 | 202 | 16 | 5 | int:KRT27 | |
| Interaction | LRRC31 interactions | 4.14e-07 | 205 | 16 | 5 | int:LRRC31 | |
| Interaction | RNF31 interactions | 4.16e-07 | 403 | 16 | 6 | int:RNF31 | |
| Interaction | CFTR interactions | 4.32e-07 | 1480 | 16 | 9 | int:CFTR | |
| Interaction | COPS6 interactions | 4.48e-07 | 408 | 16 | 6 | int:COPS6 | |
| Cytoband | 12q13.13 | 2.45e-11 | 67 | 16 | 5 | 12q13.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.24e-10 | 473 | 16 | 7 | chr17q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 2.61e-07 | 423 | 16 | 5 | chr12q13 | |
| Cytoband | 17q21.2 | 1.87e-06 | 70 | 16 | 3 | 17q21.2 | |
| GeneFamily | Keratins, type I | 1.07e-16 | 28 | 16 | 7 | 608 | |
| GeneFamily | Keratins, type II | 7.09e-09 | 27 | 16 | 4 | 609 | |
| Coexpression | MURAKAMI_UV_RESPONSE_1HR_UP | 1.26e-10 | 15 | 16 | 4 | M13308 | |
| Coexpression | LIU_CDX2_TARGETS_DN | 1.04e-08 | 8 | 16 | 3 | M19218 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 4.87e-08 | 173 | 16 | 5 | M650 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 1.11e-07 | 204 | 16 | 5 | MM966 | |
| Coexpression | MURAKAMI_UV_RESPONSE_24HR | 2.11e-07 | 20 | 16 | 3 | M17175 | |
| Coexpression | MURAKAMI_UV_RESPONSE_6HR_DN | 2.47e-07 | 21 | 16 | 3 | M16756 | |
| Coexpression | JAEGER_METASTASIS_DN | 3.69e-07 | 260 | 16 | 5 | M10702 | |
| Coexpression | TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA | 3.09e-05 | 102 | 16 | 3 | M14455 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_UP | 4.17e-05 | 16 | 16 | 2 | M1122 | |
| Coexpression | HUMMERICH_MALIGNANT_SKIN_TUMOR_UP | 5.94e-05 | 19 | 16 | 2 | M1126 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_UP | 6.60e-05 | 20 | 16 | 2 | MM491 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON | 6.66e-05 | 132 | 16 | 3 | M3434 | |
| Coexpression | KRAS.300_UP.V1_DN | 7.94e-05 | 140 | 16 | 3 | M2874 | |
| Coexpression | KRAS.LUNG_UP.V1_DN | 8.28e-05 | 142 | 16 | 3 | M2893 | |
| Coexpression | HUMMERICH_MALIGNANT_SKIN_TUMOR_UP | 8.77e-05 | 23 | 16 | 2 | MM492 | |
| Coexpression | SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN | 8.81e-05 | 145 | 16 | 3 | M11513 | |
| Coexpression | MA_RAT_AGING_DN | 1.20e-04 | 161 | 16 | 3 | M46419 | |
| Coexpression | MA_RAT_AGING_DN | 1.41e-04 | 170 | 16 | 3 | MM16097 | |
| Coexpression | GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP | 1.73e-04 | 182 | 16 | 3 | M7624 | |
| Coexpression | DCA_UP.V1_DN | 1.81e-04 | 185 | 16 | 3 | M2760 | |
| Coexpression | GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_UP | 2.18e-04 | 197 | 16 | 3 | M6278 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_MAC_DN | 2.24e-04 | 199 | 16 | 3 | M5159 | |
| Coexpression | GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP | 2.28e-04 | 200 | 16 | 3 | M8212 | |
| Coexpression | GSE360_DC_VS_MAC_UP | 2.28e-04 | 200 | 16 | 3 | M5172 | |
| Coexpression | GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_UP | 2.28e-04 | 200 | 16 | 3 | M8201 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_39 | 2.41e-04 | 204 | 16 | 3 | MM17090 | |
| Coexpression | DESCARTES_FETAL_LUNG_SQUAMOUS_EPITHELIAL_CELLS | 2.48e-04 | 206 | 16 | 3 | M40237 | |
| Coexpression | OSADA_ASCL1_TARGETS_UP | 3.56e-04 | 46 | 16 | 2 | M8556 | |
| Coexpression | KRAS.50_UP.V1_DN | 3.72e-04 | 47 | 16 | 2 | M2876 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 5.28e-04 | 56 | 16 | 2 | MM3852 | |
| Coexpression | KRAS.600_UP.V1_DN | 6.03e-04 | 279 | 16 | 3 | M2880 | |
| Coexpression | KRAS.600.LUNG.BREAST_UP.V1_DN | 6.35e-04 | 284 | 16 | 3 | M2885 | |
| Coexpression | DESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS | 7.55e-04 | 67 | 16 | 2 | M40299 | |
| Coexpression | BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE | 8.00e-04 | 69 | 16 | 2 | M2533 | |
| Coexpression | HINATA_NFKB_TARGETS_KERATINOCYTE_UP | 1.18e-03 | 84 | 16 | 2 | M11951 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_500 | 2.69e-09 | 25 | 16 | 4 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500_k3 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500 | 1.24e-08 | 427 | 16 | 7 | Facebase_ST1_Univ_500 | |
| CoexpressionAtlas | skin | 1.95e-08 | 456 | 16 | 7 | skin | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_250 | 3.28e-07 | 206 | 16 | 5 | Facebase_ST1_Univ_250 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_100 | 4.00e-07 | 84 | 16 | 4 | Facebase_ST1_Univ_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.LC.Sk, MHCII+ CD11b+ CD45+, Skin, avg-2 | 1.52e-05 | 451 | 16 | 5 | GSM538280_500 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500_3 | 3.00e-05 | 82 | 16 | 3 | Facebase_ST1_Univ_500_3 | |
| CoexpressionAtlas | BM Top 100 - nipple cross-section | 3.22e-05 | 84 | 16 | 3 | BM Top 100 - nipple cross-section | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.23e-05 | 92 | 16 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000_k3 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_100 | 5.11e-05 | 98 | 16 | 3 | PCBC_ctl_BronchioEpithel_100 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#3 | 8.48e-05 | 325 | 16 | 4 | Arv_EB-LF_2500_K3 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.01e-04 | 123 | 16 | 3 | Arv_EB-LF_1000_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | 1.93e-04 | 769 | 16 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_500 | 2.00e-04 | 406 | 16 | 4 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_1000 | 2.38e-04 | 805 | 16 | 5 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000 | |
| CoexpressionAtlas | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K2 | 2.40e-04 | 426 | 16 | 4 | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K2 | |
| CoexpressionAtlas | tonsil | 3.19e-04 | 182 | 16 | 3 | tonsil | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500_4 | 5.20e-04 | 215 | 16 | 3 | Facebase_ST1_Univ_500_4 | |
| CoexpressionAtlas | esophagus | 7.78e-04 | 247 | 16 | 3 | esophagus | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500_k-means-cluster#4 | 8.88e-04 | 59 | 16 | 2 | Arv_EB-LF_500_K4 | |
| CoexpressionAtlas | BM Top 100 - trachea | 1.32e-03 | 72 | 16 | 2 | BM Top 100 - trachea | |
| CoexpressionAtlas | BM Top 100 - oral mucosa | 1.75e-03 | 83 | 16 | 2 | BM Top 100 - oral mucosa | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_100 | 1.92e-03 | 87 | 16 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.LC.Sk, MHCII+ CD11b+ CD45+, Skin, avg-2 | 2.10e-03 | 91 | 16 | 2 | GSM538280_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_100 | 2.43e-03 | 98 | 16 | 2 | PCBC_ctl_SmallAirwayEpithel_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000 | 2.53e-03 | 800 | 16 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000 | |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45- EpCAm+ Ly51- MHCIIhi, Thymus, avg-2 | 2.76e-03 | 384 | 16 | 3 | GSM777041_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_500 | 3.12e-03 | 401 | 16 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_500 | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.36e-09 | 190 | 16 | 5 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.36e-09 | 190 | 16 | 5 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.36e-09 | 190 | 16 | 5 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-new-cluster|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-09 | 192 | 16 | 5 | e4fb3f18da7dc6a835023db69a8d99737c39ef86 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-keratinocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-09 | 192 | 16 | 5 | 4530b3028928d089b3a71eb19a4df237f58a50ae | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.26e-09 | 196 | 16 | 5 | 03de28e1c963e99623e8b0e33bf2e8ef67dc3baa | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.42e-09 | 197 | 16 | 5 | e621d4f9d4ba5e3ef17d2b477e5e14ea0251147e | |
| ToppCell | Kidney-Keratinocytes|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 6.93e-09 | 200 | 16 | 5 | 41d83faa9f45ee7ea2ab19be8ecc6d2c5ac7fe5d | |
| ToppCell | facs-Heart-LA-24m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-07 | 161 | 16 | 4 | 248487415a0601d57ef2a6692e22a61368d0b9c8 | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-07 | 162 | 16 | 4 | 7b2949eba2b4aea239d96ed82aafab13b07624eb | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-07 | 162 | 16 | 4 | 497ae9f86a5e7946d0fde932b35719a382a6b691 | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 3.62e-07 | 172 | 16 | 4 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | facs-Heart-RV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-07 | 172 | 16 | 4 | a26a73c41e5a05c9dd47a99f3320295f684c5e54 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.79e-07 | 174 | 16 | 4 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-07 | 175 | 16 | 4 | eb87275da6f61ecb4fbc89421dfd27bead1e0f48 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-07 | 179 | 16 | 4 | 4a072526c3a524a7aed99bdb32a07a1ce1f48972 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-07 | 181 | 16 | 4 | 0756d7d315b8cdd07a3cf6cdfc8a0679786b8e6a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-07 | 181 | 16 | 4 | 3f0d88e9506d66d4e71b88c50d5187302065930f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-07 | 181 | 16 | 4 | b09947d2d7b21f96d98b87ceb6f467ea329c4092 | |
| ToppCell | PSB-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.64e-07 | 183 | 16 | 4 | 2cf798a2371c61322484ea16fdfae0acfa94f102 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-07 | 183 | 16 | 4 | 26b18d1cc5d98f185176e100bafb9bc9081c66f7 | |
| ToppCell | droplet-Skin|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-07 | 185 | 16 | 4 | 657fd191ed160f8620d57b33820ec7222806f289 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-07 | 185 | 16 | 4 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-07 | 186 | 16 | 4 | 9a7932d0a208f3997216bd21a72913cc82b59fc9 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-07 | 186 | 16 | 4 | 2913b5fd0617d024d600ba7015ec7b1961dade83 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-07 | 188 | 16 | 4 | ed35e438796cef302b6787c111753425922792dc | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.50e-07 | 191 | 16 | 4 | cd4e2e883c4955fb2d875e41bb6ebc680994dc8c | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.62e-07 | 192 | 16 | 4 | 103496f428f59683ac3ae6147682c07c30663724 | |
| ToppCell | facs-Trachea-18m-Epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.62e-07 | 192 | 16 | 4 | c5823c5d4c58a4e9121a4b7d7256481d6d9e9b7f | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-07 | 193 | 16 | 4 | f074ebf9c5c53d8589d66b0109505f30baa1af81 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-07 | 193 | 16 | 4 | a7002acf3be76b2cc6fc9364176f6b0d3bd27d9c | |
| ToppCell | NS-critical-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.86e-07 | 194 | 16 | 4 | 614d0c25b56957c70f397abb169fd2a860eb1c06 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-keratinocyte-new-cluster|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-07 | 194 | 16 | 4 | b847c5b4e8914b1c306bfff3d7119c32063784a8 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-keratinocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-07 | 194 | 16 | 4 | bd94d30584128628b34ed8c3857ce103586cfe2e | |
| ToppCell | droplet-Tongue|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-07 | 195 | 16 | 4 | e460b09ae354b579ce552acebdaa5877a6e62343 | |
| ToppCell | facs-Tongue|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-07 | 195 | 16 | 4 | 77128895db9221a64a171082d468ebcd6380c936 | |
| ToppCell | moderate-Epithelial-Squamous|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.23e-07 | 197 | 16 | 4 | ab3c90a5b643b45d0b83939c6304b11f567c5d78 | |
| ToppCell | moderate-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.23e-07 | 197 | 16 | 4 | 2e13881f917d4f62a5b3e968e41c57e43300d988 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.23e-07 | 197 | 16 | 4 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.23e-07 | 197 | 16 | 4 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.23e-07 | 197 | 16 | 4 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.23e-07 | 197 | 16 | 4 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.23e-07 | 197 | 16 | 4 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.35e-07 | 198 | 16 | 4 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | Skin|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 6.48e-07 | 199 | 16 | 4 | 6be1340413ee868c610b6e3f58c65b493eb22bb5 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-C1ql2-Excitatory_Neuron.Slc17a7.C1ql2-Penk_(Dentate_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.38e-06 | 62 | 16 | 3 | 385e7de8b6d81052ee7dfc0958c7b3d924f73130 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.C1ql3_(Hippocampus_Excitatory_Neuron)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.33e-06 | 97 | 16 | 3 | 1da964954a95c497ac4a24df1ea3575df5747025 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.33e-06 | 97 | 16 | 3 | dd188763ba02337e4f25d56766eda886cffa810d | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.33e-06 | 97 | 16 | 3 | a0242258aad0766450ff52fe28278cbb2b8d63a0 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.C1ql3_(Hippocampus_Excitatory_Neuron)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.33e-06 | 97 | 16 | 3 | 98a31b9bf0adcad1cb1d803bf7a23d49b4e1f2d5 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 130 | 16 | 3 | 4c8b931987432e8bcd39029d4fa124dc383ea355 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.31e-05 | 131 | 16 | 3 | 9ca209a8652aae603c4a867ea06b06ac51e7d189 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 139 | 16 | 3 | da8874d441b8e69c94bad771635f378ddafb49fe | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.74e-05 | 144 | 16 | 3 | e2a2f260f5ebaaef46248d199c407a15ce9d024a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 149 | 16 | 3 | d259e9137109eeb2662022f0915ca463f5bebdfe | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.26e-05 | 157 | 16 | 3 | 2553ebf3e48de5bd184e77bd61114faa5a1d95ed | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.30e-05 | 158 | 16 | 3 | 98712ed7e8e65e8c5ff9318cf0e0a04e271a055d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.34e-05 | 159 | 16 | 3 | 0dccc4275b9b4f8554dd556da7218e130bff8fd1 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 160 | 16 | 3 | 8590281165eab6514a9f6a022b900d4c222c1044 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.53e-05 | 163 | 16 | 3 | 6a12b802cb181f979ebc72674f3626fb855024e3 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.53e-05 | 163 | 16 | 3 | bba830a302919c8b33f914a8839877fc21dd28a0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.53e-05 | 163 | 16 | 3 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.57e-05 | 164 | 16 | 3 | 08819970174a3eb4eee8e1e675075828665b845e | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 167 | 16 | 3 | 02c89069dcd0e87f7502e32b14e7cbd3cab81a09 | |
| ToppCell | facs-Marrow-T-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 168 | 16 | 3 | 0ece1e196d17c0f276424abd5cb43d528f40224b | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.81e-05 | 169 | 16 | 3 | 4a5d023ffcf83312d29b1d215eb6b744ef1a0777 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-05 | 172 | 16 | 3 | 5ca89af7406e7e1a055dd60d6f89615f69e62324 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 173 | 16 | 3 | 0f9c1d3298e59e6d22bb3306f0f445f490be8bbd | |
| ToppCell | (00)_Basal-(1)_24hpi|(00)_Basal / shred by cell type and Timepoint | 3.02e-05 | 173 | 16 | 3 | a8e62e7d8baf6af691acd5c50deedbadc119ceba | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Squamous|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.07e-05 | 174 | 16 | 3 | 0a4721248ec89bc98ebe119de6e19fbfca8b5098 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Myeloid-macrophage|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 174 | 16 | 3 | 84f2ffe867f22d2fa79f28737a0aa42bdf2f4804 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 175 | 16 | 3 | 3883675a726dd0c6c3a7113d59be2a093ea2dc6f | |
| ToppCell | facs-Heart-RV-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 175 | 16 | 3 | bde002379088c0407afd0f3dae60b6a166683957 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.23e-05 | 177 | 16 | 3 | a0c7d08469c513cecf87777c19876884f1511570 | |
| ToppCell | facs-Trachea-nan-18m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 177 | 16 | 3 | fc30276903bcb1e95ae76f6cee3d17408158941a | |
| ToppCell | facs-Trachea-18m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.23e-05 | 177 | 16 | 3 | 68c9a8a82c956cbfdf03b44984c97f978aaaf80f | |
| ToppCell | facs-Brain_Myeloid-Striatum|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 177 | 16 | 3 | efb1990fd1d216f64261e81017299783afb24a1e | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 178 | 16 | 3 | 6d9ecfaeb50d562899380de379ebf7b99fd8adc9 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 178 | 16 | 3 | d3f518cd75b02e85d45cbb9b2eff30f0272512a8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.28e-05 | 178 | 16 | 3 | e86ed30652c2de70f16430f04b78789b87df4af2 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 181 | 16 | 3 | 41969fe4d94ee77b12ecde32170aaf0b13e49644 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 181 | 16 | 3 | 3f50e61dc2a52d71a5801584617607e6246adcf2 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.51e-05 | 182 | 16 | 3 | 007fa56ed8b91f9af0df2114c00410b2f6cec8b6 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-05 | 183 | 16 | 3 | ed1e0b07475f9951728682ed70b85367cf2a744d | |
| ToppCell | facs-Skin-nan-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 184 | 16 | 3 | dc7f6ee4062856a02423fff8b1cce62d46a9355c | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_proximal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.62e-05 | 184 | 16 | 3 | 575de705053da8b289670b5c40c1627c0833b5ed | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.68e-05 | 185 | 16 | 3 | f3fbc3096f85397a959cee17c3c4fcf2d511f3d5 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 186 | 16 | 3 | 18c06041c6c8a0ebac17b3c8aaebd67e652d315a | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.80e-05 | 187 | 16 | 3 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | facs-Trachea-nan-18m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-05 | 187 | 16 | 3 | 8882a638af7165b2910ba8e932d55475d7bfb003 | |
| ToppCell | SupraBC-Differ-KC|World / shred by cell class for mouse tongue | 3.92e-05 | 189 | 16 | 3 | 6412741b88e241304033b41effca0c77a374d907 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.92e-05 | 189 | 16 | 3 | 533c302df467d13ab639232daf4f8cafb808260b | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.92e-05 | 189 | 16 | 3 | aa4f7d7a5196e5ae481ebc2549de8e3f0ef6e6be | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 190 | 16 | 3 | 719a5cecc3e8001ca9c38165258b5ff9c800713a | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 190 | 16 | 3 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 191 | 16 | 3 | c5ef34d138cd797029dfefaf4c52d16ba6a76c38 | |
| ToppCell | facs-Skin|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 191 | 16 | 3 | ae524103331fa53fa82888dbb567fc36abcee7e0 | |
| ToppCell | facs-Tongue-nan-18m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 191 | 16 | 3 | 02f24202f9fdd46c648265a5b3b6f9066aa009fc | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-05 | 192 | 16 | 3 | c7185fbc56ffd4c62db47fc240b3207ef65db40e | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-basal_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.18e-05 | 193 | 16 | 3 | 83d2dd823808a2b5ca1a6889eefb541ec042b24c | |
| Computational | Keratin. | 2.52e-11 | 26 | 11 | 5 | MODULE_298 | |
| Computational | Genes in the cancer module 68. | 2.52e-11 | 26 | 11 | 5 | MODULE_68 | |
| Computational | Genes in the cancer module 153. | 2.71e-08 | 34 | 11 | 4 | MODULE_153 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.33e-07 | 50 | 11 | 4 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN | |
| Computational | Developmental processes. | 1.10e-05 | 333 | 11 | 5 | MODULE_220 | |
| Computational | Intermediate filaments and MT. | 3.85e-05 | 68 | 11 | 3 | MODULE_438 | |
| Computational | Genes in the cancer module 297. | 6.27e-05 | 80 | 11 | 3 | MODULE_297 | |
| Computational | Intermediate filaments and keratins. | 6.27e-05 | 80 | 11 | 3 | MODULE_357 | |
| Computational | Neighborhood of SPRR1B | 2.60e-04 | 24 | 11 | 2 | GNF2_SPRR1B | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.14e-03 | 50 | 11 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_19_EPITHELIAL_SENESCENCE | |
| Computational | Neighborhood of ITGA2 | 1.42e-03 | 56 | 11 | 2 | MORF_ITGA2 | |
| Computational | Genes in the cancer module 322. | 1.58e-03 | 59 | 11 | 2 | MODULE_322 | |
| Computational | Neighborhood of MYL3 | 2.21e-03 | 70 | 11 | 2 | MORF_MYL3 | |
| Computational | Neighborhood of PDCD1 | 2.40e-03 | 73 | 11 | 2 | MORF_PDCD1 | |
| Computational | Intermediate filaments. | 2.54e-03 | 75 | 11 | 2 | MODULE_154 | |
| Computational | Genes in the cancer module 181. | 3.18e-03 | 306 | 11 | 3 | MODULE_181 | |
| Computational | Genes in the cancer module 104. | 4.76e-03 | 353 | 11 | 3 | MODULE_104 | |
| Computational | Neighborhood of CD8A | 7.00e-03 | 126 | 11 | 2 | MORF_CD8A | |
| Computational | Neighborhood of MAGEA9 | 7.88e-03 | 423 | 11 | 3 | MORF_MAGEA9 | |
| Drug | teleocidin B | 1.14e-19 | 123 | 16 | 10 | CID000072425 | |
| Drug | sulfur mustard | 2.01e-19 | 130 | 16 | 10 | CID000010461 | |
| Drug | homocysteine thiolactone | 2.18e-19 | 131 | 16 | 10 | CID000107712 | |
| Drug | al-Badry | 2.34e-18 | 165 | 16 | 10 | CID000004545 | |
| Drug | AC1L9MJT | 1.94e-15 | 192 | 16 | 9 | CID000448959 | |
| Drug | Velcade (bortezomib | 9.31e-15 | 374 | 16 | 10 | CID000093860 | |
| Drug | 1-2q | 7.99e-14 | 289 | 16 | 9 | CID000011820 | |
| Drug | AC1L1GT5 | 1.95e-13 | 95 | 16 | 7 | CID000003829 | |
| Drug | butyrate | KRT1 KRT2 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 SP7 | 2.21e-13 | 767 | 16 | 11 | CID000000264 |
| Drug | NSC34533 | 1.05e-12 | 54 | 16 | 6 | CID000003512 | |
| Drug | phenyl isocyanate | 2.44e-12 | 6 | 16 | 4 | ctd:C025319 | |
| Drug | olomoucine II | 6.86e-12 | 27 | 16 | 5 | CID005494414 | |
| Drug | ethylnylestradiol | KRT1 KRT2 KRT9 KRT10 KRT77 KRT13 KRT14 KRT76 KRT24 KRT16 SP7 | 4.47e-11 | 1251 | 16 | 11 | CID000003285 |
| Drug | adenosine 3',5'-cyclic phosphate | 6.17e-11 | 907 | 16 | 10 | CID000000274 | |
| Drug | dithranol | 4.95e-10 | 18 | 16 | 4 | CID000002202 | |
| Drug | 9-cis-acitretin | 1.09e-09 | 71 | 16 | 5 | CID000041317 | |
| Drug | Lh 1 | 1.18e-09 | 22 | 16 | 4 | CID000191841 | |
| Drug | 1pxm | 1.76e-09 | 78 | 16 | 5 | CID000447959 | |
| Drug | AC1NQZM2 | 3.82e-09 | 29 | 16 | 4 | CID005282177 | |
| Drug | phorbol acetate myristate | 4.23e-09 | 1399 | 16 | 10 | CID000004792 | |
| Drug | NSC134723 | 5.69e-09 | 6 | 16 | 3 | CID000281830 | |
| Drug | Chromates | 2.39e-08 | 9 | 16 | 3 | ctd:D002840 | |
| Drug | DMBA | 3.38e-08 | 140 | 16 | 5 | CID000006001 | |
| Drug | CK17 | 6.28e-08 | 57 | 16 | 4 | CID000128831 | |
| Drug | CK 6 | 6.74e-08 | 58 | 16 | 4 | CID000447960 | |
| Drug | triphenyltin | 8.11e-08 | 13 | 16 | 3 | CID005357402 | |
| Drug | Ro 13-6298 | 8.11e-08 | 13 | 16 | 3 | CID006437076 | |
| Drug | K-11 | 1.92e-07 | 17 | 16 | 3 | CID000469667 | |
| Drug | beta-damascenone | 5.71e-07 | 24 | 16 | 3 | ctd:C075388 | |
| Drug | Bi-E | 8.24e-07 | 27 | 16 | 3 | CID006914595 | |
| Drug | [(2R,3R,4R,5S,6R)-2-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-5-hydroxy-6-(hydroxymethyl)-3-[(2-tritioacetyl)amino]oxan-4-yl] (3R)-3-hydroxydecanoate | 9.23e-07 | 28 | 16 | 3 | CID011650719 | |
| Drug | K-13 | 1.26e-06 | 31 | 16 | 3 | CID000469669 | |
| Drug | N8T | 1.39e-06 | 3 | 16 | 2 | CID006540271 | |
| Drug | CD367 | 1.53e-06 | 33 | 16 | 3 | CID000119342 | |
| Drug | bromovanin | 1.60e-06 | 127 | 16 | 4 | ctd:C515564 | |
| Drug | chrysarobin | 2.18e-06 | 37 | 16 | 3 | CID000068111 | |
| Drug | I5B1 | 2.18e-06 | 37 | 16 | 3 | CID005487705 | |
| Drug | liarozole | 2.56e-06 | 39 | 16 | 3 | CID000060652 | |
| Drug | tazarotene | 2.77e-06 | 40 | 16 | 3 | CID000005381 | |
| Drug | chromium nitrate | 3.45e-06 | 43 | 16 | 3 | ctd:C041167 | |
| Drug | A805480 | 3.71e-06 | 44 | 16 | 3 | CID000620368 | |
| Drug | D-glucamine | 3.97e-06 | 45 | 16 | 3 | CID000027282 | |
| Drug | VML 295 | 3.97e-06 | 45 | 16 | 3 | CID000177941 | |
| Drug | dimethyl phthalate | 5.70e-06 | 714 | 16 | 6 | ctd:C024629 | |
| Drug | ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid | 6.93e-06 | 6 | 16 | 2 | ctd:C034814 | |
| Drug | cignolin | 7.72e-06 | 56 | 16 | 3 | CID000010187 | |
| Drug | R-Te | 8.14e-06 | 57 | 16 | 3 | CID000068913 | |
| Drug | AC1O3H1D | 1.33e-05 | 67 | 16 | 3 | CID006328166 | |
| Drug | dicyclohexyl phthalate | 1.41e-05 | 836 | 16 | 6 | ctd:C036042 | |
| Drug | Divonex | 1.45e-05 | 69 | 16 | 3 | CID000002522 | |
| Drug | antipsoriatic | 1.58e-05 | 71 | 16 | 3 | CID000005585 | |
| Drug | 4-oxoretinoic acid | 2.02e-05 | 77 | 16 | 3 | CID006437063 | |
| Drug | calcipotriene | 2.54e-05 | 11 | 16 | 2 | ctd:C055085 | |
| Drug | AC1O0B8G | 2.80e-05 | 262 | 16 | 4 | CID000091605 | |
| Drug | monomethyl phthalate | 3.02e-05 | 957 | 16 | 6 | ctd:C517284 | |
| Drug | tiflucarbine | 3.04e-05 | 12 | 16 | 2 | CID000065677 | |
| Drug | K 2S | 3.60e-05 | 13 | 16 | 2 | CID000014800 | |
| Drug | AC1O517G | 5.52e-05 | 16 | 16 | 2 | CID006450188 | |
| Drug | bexarotene | 6.03e-05 | 111 | 16 | 3 | CID000082146 | |
| Drug | clobestasol propionate | 6.26e-05 | 17 | 16 | 2 | CID000002791 | |
| Drug | 4-oxoretinoic acid | 6.70e-05 | 115 | 16 | 3 | ctd:C002202 | |
| Drug | JTV-519 | 7.04e-05 | 18 | 16 | 2 | CID000001715 | |
| Drug | N-nitrosomorpholine | 7.54e-05 | 338 | 16 | 4 | ctd:C002741 | |
| Drug | K 10 | 7.86e-05 | 19 | 16 | 2 | CID000221089 | |
| Drug | Arsenates | 7.99e-05 | 122 | 16 | 3 | ctd:D001149 | |
| Drug | dichloromethyl | 8.73e-05 | 20 | 16 | 2 | CID000123193 | |
| Drug | Olux | 8.73e-05 | 20 | 16 | 2 | CID000032797 | |
| Drug | AC1L24BB | 9.65e-05 | 21 | 16 | 2 | CID000065952 | |
| Drug | Ak 2 | 9.65e-05 | 21 | 16 | 2 | CID006475484 | |
| Drug | fluoropyruvate | 1.16e-04 | 23 | 16 | 2 | CID000067946 | |
| Drug | sandostatinLAR | 1.28e-04 | 143 | 16 | 3 | ctd:C541923 | |
| Drug | perfluorododecanoic acid | 1.31e-04 | 144 | 16 | 3 | ctd:C522391 | |
| Drug | mosidal | 1.61e-04 | 27 | 16 | 2 | CID003032288 | |
| Drug | C15873 | 1.61e-04 | 27 | 16 | 2 | CID000045749 | |
| Drug | AC1L9H5I | 1.61e-04 | 27 | 16 | 2 | CID000444945 | |
| Drug | Diethylstilbestrol | 1.71e-04 | 1305 | 16 | 6 | ctd:D004054 | |
| Drug | CH2Cl | 1.73e-04 | 28 | 16 | 2 | CID005378701 | |
| Drug | betamethasone valerate | 1.73e-04 | 28 | 16 | 2 | CID000016533 | |
| Drug | beta-Naphthoflavone | 1.96e-04 | 828 | 16 | 5 | ctd:D019324 | |
| Drug | Mustard Gas | 1.98e-04 | 1341 | 16 | 6 | ctd:D009151 | |
| Drug | GW0742 | 2.13e-04 | 31 | 16 | 2 | ctd:C479979 | |
| Drug | Morphine | 2.19e-04 | 446 | 16 | 4 | ctd:D009020 | |
| Drug | AC1N9J6O | 2.61e-04 | 182 | 16 | 3 | CID004411483 | |
| Drug | AC1MQZ6I | 2.96e-04 | 190 | 16 | 3 | CID003509873 | |
| Drug | sodium chromate(VI) | 3.04e-04 | 37 | 16 | 2 | ctd:C028982 | |
| Drug | N-hydroxyurethane | 3.04e-04 | 37 | 16 | 2 | CID000011510 | |
| Drug | SKF-7261 | 3.21e-04 | 38 | 16 | 2 | CID000015773 | |
| Drug | Oxolinic acid [14698-29-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 5519_UP | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; HL60; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 3117_UP | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Up 200; 11.6uM; PC3; HT_HG-U133A | 3.44e-04 | 200 | 16 | 3 | 4202_UP | |
| Drug | AC1L9LFC | 3.56e-04 | 40 | 16 | 2 | CID000447953 | |
| Drug | glycylglycylglycine | 3.56e-04 | 40 | 16 | 2 | CID000011161 | |
| Drug | CD437 | 3.59e-04 | 203 | 16 | 3 | CID000135411 | |
| Drug | GDCA | 3.74e-04 | 41 | 16 | 2 | CID000003493 | |
| Drug | AC1L9MBG | 3.92e-04 | 42 | 16 | 2 | CID000448761 | |
| Drug | Roxarsone | 3.92e-04 | 42 | 16 | 2 | ctd:D012406 | |
| Drug | 2,4-diacetylphloroglucinol | 4.31e-04 | 44 | 16 | 2 | CID000016547 | |
| Drug | N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester | 4.31e-04 | 44 | 16 | 2 | ctd:C419410 | |
| Drug | Etretinate-d3 | 4.50e-04 | 45 | 16 | 2 | CID000003312 | |
| Drug | PHEMA | 5.34e-04 | 49 | 16 | 2 | CID000013360 | |
| Disease | Keratoderma, Palmoplantar | 7.84e-11 | 16 | 15 | 4 | C4551675 | |
| Disease | Keratoderma, Palmoplantar, Epidermolytic | 1.06e-10 | 3 | 15 | 3 | C1721006 | |
| Disease | Epidermolytic palmoplantar keratoderma Vorner type | 1.06e-10 | 3 | 15 | 3 | C2931735 | |
| Disease | Epidermolytic palmoplantar keratoderma of Vorner | 1.06e-10 | 3 | 15 | 3 | C0343110 | |
| Disease | Ichthyosis, Cyclic, with Epidermolytic Hyperkeratosis | 2.41e-07 | 2 | 15 | 2 | C1843463 | |
| Disease | Epidermolytic ichthyosis | 2.41e-07 | 2 | 15 | 2 | cv:C0079153 | |
| Disease | Erythrokeratoderma, Reticular | 2.41e-07 | 2 | 15 | 2 | C1836681 | |
| Disease | Annular epidermolytic ichthyosis | 2.41e-07 | 2 | 15 | 2 | cv:C1843463 | |
| Disease | epidermolytic hyperkeratosis (is_implicated_in) | 2.41e-07 | 2 | 15 | 2 | DOID:4603 (is_implicated_in) | |
| Disease | cinnamaldehyde measurement | 2.41e-07 | 2 | 15 | 2 | EFO_0021839 | |
| Disease | Palmoplantar keratoderma, epidermolytic | 2.41e-07 | 2 | 15 | 2 | cv:C1721006 | |
| Disease | Congenital reticular ichthyosiform erythroderma | 2.41e-07 | 2 | 15 | 2 | C3665704 | |
| Disease | Keratosis of Greither | 2.41e-07 | 2 | 15 | 2 | C2936837 | |
| Disease | Squamous cell carcinoma | 3.91e-07 | 124 | 15 | 4 | C0007137 | |
| Disease | epidermolytic hyperkeratosis (implicated_via_orthology) | 7.23e-07 | 3 | 15 | 2 | DOID:4603 (implicated_via_orthology) | |
| Disease | Pachyonychia Congenita | 2.41e-06 | 5 | 15 | 2 | C0265334 | |
| Disease | Hyperkeratosis, Epidermolytic | 2.41e-06 | 5 | 15 | 2 | C0079153 | |
| Disease | Skin Neoplasms | 3.40e-06 | 59 | 15 | 3 | C0037286 | |
| Disease | Malignant neoplasm of skin | 3.40e-06 | 59 | 15 | 3 | C0007114 | |
| Disease | insulin sensitivity measurement, glucose homeostasis measurement | 2.15e-04 | 43 | 15 | 2 | EFO_0004471, EFO_0006896 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NFSGRGGFGGSCGGG | 221 | Q32P51 | |
| SSCGFAGGYGGGFGG | 86 | Q01546 | |
| YSSSRSGGGGGGGGC | 11 | P13645 | |
| SSGGGCFGGSSGGYG | 61 | P13645 | |
| CFGGSSGGYGGLGGF | 66 | P13645 | |
| GGSSGGGYGGGSSSG | 506 | P13645 | |
| GHGGSSSGGYGGGSS | 521 | P13645 | |
| GYGGGSSGGGSSSGG | 541 | P13645 | |
| SSGGGSSSGGGYGGG | 546 | P13645 | |
| SSSGGGYGGGSSSGG | 551 | P13645 | |
| SGGSYGGGSGSGGGS | 516 | P35527 | |
| GACGLGGGYGGGFSS | 61 | P02533 | |
| SSSGGGYGSGGGGSS | 606 | P35908 | |
| SYGGGFGGGSCQLGG | 11 | P13646 | |
| SAGGYGGGVSCGFGG | 41 | P13646 | |
| CGFGGGAGSGFGGGY | 51 | P13646 | |
| FSSCGGGGGSFGAGG | 46 | P04264 | |
| GGGGYGSGGSSYGSG | 521 | P04264 | |
| SYGSGGGSYGSGGGG | 531 | P04264 | |
| GGGGHGSYGSGSSSG | 571 | P04264 | |
| FSSGGACGLGGGYGG | 56 | P08779 | |
| ACGLGGGYGGGFSSS | 61 | P08779 | |
| GGSFGGGFGSCSVGG | 61 | Q2M2I5 | |
| GGFGSCSVGGGFGGA | 66 | Q2M2I5 | |
| GGYGGGLGGGSASCA | 56 | Q7Z3Y8 | |
| GSGGGSSGSGCGYSG | 41 | P23490 | |
| SSGSGCGYSGGGGYS | 46 | P23490 | |
| GGGYSGGGCGGGSSG | 56 | P23490 | |
| SGGGGSSGGGSGCFS | 91 | P23490 | |
| SSGGGSGCFSSGGGG | 96 | P23490 | |
| SGCFSSGGGGSSGGG | 111 | P23490 | |
| SGGGGSSGGGSGCFS | 116 | P23490 | |
| SSGGGSGCFSSGGGG | 121 | P23490 | |
| SGCFSSGGGGSSGGG | 126 | P23490 | |
| SGGGGSSGGGSGCFS | 131 | P23490 | |
| SSGGGSGCFSSGGGG | 136 | P23490 | |
| SGGSSGGGSGCFSSG | 166 | P23490 | |
| GGGGSVCGYSGGGSG | 181 | P23490 | |
| CGGGSSGGSGSGYVS | 196 | P23490 | |
| GGSGCFSSGGGGGSS | 236 | P23490 | |
| ETRGGFGGGGGGCSS | 916 | Q9UM73 | |
| GSGGYGGSGAGRSSC | 256 | Q8TDD2 | |
| SGGGSCGGGGSYSAS | 41 | Q15022 | |
| GCGGGGGSYGGSGRS | 541 | Q7Z794 |